Overview

Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial which will evaluate the efficacy of Liprotamase treatment in cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (PI).
Phase:
Phase 3
Details
Lead Sponsor:
Anthera Pharmaceuticals